Indian J Pharm Close
 

Table 2: Question 1 (i): What is the fraction of advanced/metastatic breast cancer patients with HR +ve/Her2 −ve phenotype in your practice?

Table 2: Question 1 (i): What is the fraction of advanced/metastatic breast cancer patients with HR +ve/Her2 −ve phenotype in your practice?